Open Call#2 for Accelerating Data-Driven Solutions to Save Lives from COVID-19

The consortium of COVID-X announces the launch of Open Call #2 for a unique acceleration programme in Europe to fast-track to market 15+ European data technology solutions, addressing COVID-19 challenges and facilitating an innovative stack of AI-driven tools in order to defeat the pandemic.

COVID-X Programme, supported by the European Commission under Horizon2020 programme, funds European companies and healthcare providers to boost 30+ data-driven solutions to the markets to overcome clinical challenges in diagnosis, prognosis, and follow-up. The funding is invested in solutions with TRL 7+ and [or in the process of] CE marking, covering two profiles: single solution (EU tech SMEs / Start-Ups) validating their solutions at one of COVID-X pilot sites; or team solution (Tech provider bringing in a healthcare provider that will validate the solution).

In addition to the direct funding, the COVID-X Programme provides the top-ranked solutions access in a tailored acceleration programme organized in 3 sprints of 3 months each. These include technical coaching, business mentoring sessions as well as support in ethical issues and piloting with healthcare organizations. This 10-month programme targets to boost the quick market uptake to defeat COVID-19 with data solutions.

To attract top-notch solutions meeting the set selection criteria, the Open Call#2 has a two-stage application process: In the first stage, the applicant's eligibility and alignment with the selection criteria are assessed. All eligible applications access the 2nd stage where the complete application form with detailed information about the solution & implementation is required.

The COVID-X Programme Open Call #1 closed on 27.1.2021 gathering 112 applications from data technology companies and healthcare providers coming from 29 different countries in Europe and beyond. 16 selected single and team solutions were selected and are now completing the 1st Sprint of the programme.

The Open Call#2 application is now open and the deadline for the first stage will be on the 22nd of July 2021. (17:00PM CEST).

For further infromation, please visit:
https://www.covid-x.eu/apply-now/

Most Popular Now

Mobile Phone Data Helps Track Pathogen S…

A new way to map the spread and evolution of pathogens, and their responses to vaccines and antibiotics, will provide key insights to help predict and prevent future outbreaks. The...

AI Model to Improve Patient Response to …

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The Australian National University (ANU). DeepPT, developed...

Can AI Tell you if You Have Osteoporosis…

Osteoporosis is so difficult to detect in early stage it’s called the "silent disease." What if artificial intelligence could help predict a patient’s chances of having the bone-loss disease before...

Study Reveals Why AI Models that Analyze…

Artificial intelligence (AI) models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don’t always...

Think You're Funny? ChatGPT might b…

A study comparing jokes by people versus those told by ChatGPT shows that humans need to work on their material. The research team behind the study published on Wednesday, July 3...

Innovative, Highly Accurate AI Model can…

If there is one medical exam that everyone in the world has taken, it's a chest x-ray. Clinicians can use radiographs to tell if someone has tuberculosis, lung cancer, or...

New AI Approach Optimizes Antibody Drugs

Proteins have evolved to excel at everything from contracting muscles to digesting food to recognizing viruses. To engineer better proteins, including antibodies, scientists often iteratively mutate the amino acids -...

AI Speeds Up Heart Scans, Saving Doctors…

Researchers have developed a groundbreaking method for analysing heart MRI scans with the help of artificial intelligence (AI), which could save valuable NHS time and resources, as well as improve...

Researchers Customize AI Tools for Digit…

Scientists from Weill Cornell Medicine and the Dana-Farber Cancer Institute in Boston have developed and tested new artificial intelligence (AI) tools tailored to digital pathology - a rapidly growing field...

Young People Believe that AI is a Valuab…

Children and young people are generally positive about artificial intelligence (AI) and think it should be used in modern healthcare, finds the first-of-its-kind survey led by UCL and Great Ormond...